JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

Search

Kala Pharmaceuticals Inc

Closed

0.79 5.33

Overview

Share price change

24h

Current

Min

0.72

Max

0.79

Key metrics

By Trading Economics

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+957.69% upside

Dividends

By Dow Jones

Next Earnings

10 Nov 2025

Kala Pharmaceuticals Inc Chart

Past performance is not a reliable indicator of future results.

Related News

31 Oct 2025, 17:40 UTC

Acquisitions, Mergers, Takeovers

Orange to Buy Lorca's 50% Stake in MasOrange for $4.9 Billion

31 Oct 2025, 23:09 UTC

Earnings

Review & Preview: October Surprise -- Barrons.com

31 Oct 2025, 22:44 UTC

Acquisitions, Mergers, Takeovers

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- WSJ

31 Oct 2025, 21:25 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Pfizer Says Novo Nordisk's Metsera Bid Won't Pass Antitrust Laws -- Market Talk

31 Oct 2025, 21:20 UTC

Acquisitions, Mergers, Takeovers

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- Update

31 Oct 2025, 21:12 UTC

Acquisitions, Mergers, Takeovers

Pfizer Sues Metsera, Novo Nordisk, Claiming Novo Nordisk Takeover Offer Isn't Superior -- WSJ

31 Oct 2025, 21:12 UTC

Acquisitions, Mergers, Takeovers

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- WSJ

31 Oct 2025, 21:12 UTC

Acquisitions, Mergers, Takeovers

Pfizer Seeks Order Blocking Metsera From Terminating Its Merger Deal With Pfizer -- WSJ

31 Oct 2025, 20:51 UTC

Acquisitions, Mergers, Takeovers

Another Rare-Earth Stock Jumps on Government Deal -- Barrons.com

31 Oct 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

31 Oct 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

31 Oct 2025, 20:50 UTC

Market Talk
Earnings

Auto & Transport Roundup: Market Talk

31 Oct 2025, 20:46 UTC

Acquisitions, Mergers, Takeovers

Pfizer: Files Lawsuit Against Metsera and Its Directors and Novo Nordisk for Breach of Merger Agreement

31 Oct 2025, 20:22 UTC

Earnings

Amazon Stock Hits New Record. What Was So Good in Its Earnings Report. -- Barrons.com

31 Oct 2025, 20:02 UTC

Earnings

Meta Faces a Sudden Reckoning. How Big Tech Earnings Are Reshaping the AI Race. -- Barrons.com

31 Oct 2025, 19:55 UTC

Market Talk

Crude Futures Fall for Third Straight Month -- Market Talk

31 Oct 2025, 19:54 UTC

Acquisitions, Mergers, Takeovers

Pfizer: FTC Granted Early Termination of Waiting Period >PFE

31 Oct 2025, 19:54 UTC

Acquisitions, Mergers, Takeovers

Pfizer: Receives Early Clearance From FTC for Metsera Acquisition

31 Oct 2025, 19:26 UTC

Market Talk

U.S. Natural Gas Rises on Winter Outlook, Strong LNG -- Market Talk

31 Oct 2025, 18:30 UTC

Earnings

These Stocks Are Moving the Most Today: Amazon, Nvidia, Apple, Netflix, Exxon, DexCom, Coinbase, Reddit, Newell Brands, and More -- Barrons.com

31 Oct 2025, 18:23 UTC

Market Talk

Gold Edges Lower for the Day, Closes October Positive -- Market Talk

31 Oct 2025, 18:09 UTC

Earnings

Bank of America Has a Game Plan to Catch Up to Its Peers. It's Time to Buy the Stock. -- Barrons.com

31 Oct 2025, 18:08 UTC

Earnings

Bank of America Has a Game Plan to Catch Up to Its Peers. It's Time to Buy the Stock. -- Barrons.com

31 Oct 2025, 17:36 UTC

Market Talk

Grain Futures Shrug Off Stronger Dollar -- Market Talk

31 Oct 2025, 17:31 UTC

Market Talk

U.S. Oil Rig Count Falls, Natural Gas Rig Count Rises -- Market Talk

31 Oct 2025, 17:16 UTC

Acquisitions, Mergers, Takeovers

Orange: Acquisition Likely Completed in First Half Next Year

31 Oct 2025, 17:15 UTC

Acquisitions, Mergers, Takeovers

Orange: Agreement Set to Be Signed By Year-Out

31 Oct 2025, 17:14 UTC

Acquisitions, Mergers, Takeovers

Orange: Acquisition Will Strengthen Position in Spain

31 Oct 2025, 17:13 UTC

Acquisitions, Mergers, Takeovers

Orange Will Be Sole Owner of Spain's MasOrange Following Acquisition of Lorca's Stake

31 Oct 2025, 17:12 UTC

Acquisitions, Mergers, Takeovers

Orange Reaches Deal to Buy Lorca's 50% Stake in MasOrange for EUR4.25B

Peer Comparison

Price change

Kala Pharmaceuticals Inc Forecast

Price Target

By TipRanks

957.69% upside

12 Months Forecast

Average 8.25 USD  957.69%

High 15 USD

Low 1.5 USD

Based on 3 Wall Street analysts offering 12 month price targets forKala Pharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

3 ratings

1

Buy

2

Hold

0

Sell

Financials

$

About Kala Pharmaceuticals Inc

Kala Pharmaceuticals Inc
help-icon Live chat